一个新的工具支持选择最佳的造血干细胞捐赠者通过模拟本地自己的真实世界数据
Roberto Crocchiolo1, Stefania Cacace2, Giuseppe Milone3
1Servizio di Immunoematologia e Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, 20162 Milano, Italy.
Journal of clinical medicine
|November 27, 2024
概括
一个新的计算器通过预测患者的存活率来帮助选择最适合血造干细胞移植 (HSCT) 的捐赠者. 这个工具使用移植中心的数据来指导医生在HLA相同的兄弟姐妹和单双相同的捐赠者之间做出选择.
科学领域:
- 血液学 血液学 血液学
- 移植免疫学 移植免疫学
- 医疗信息学 医疗信息学
背景情况:
- 供体选择对于全源造血干细胞移植 (HSCT) 的成功至关重要.
- 在多个合适的选项中选择最佳捐赠者是一个重大的临床挑战.
研究的目的:
- 开发和验证HSCT中供体选择的预测工具.
- 支持移植医生做出关于个人患者最佳捐赠者的明智决策.
主要方法:
- 从两个中心 (2010年1月至2022年7月) 追溯分析了737例HSCT病例.
- 开发一种利用患者年龄,疾病,并发症指数和捐赠者类型 (HLA相同的兄弟姐妹,无关/无关的单一) 的计算器,以预测2年总生存期 (OS).
主要成果:
- 患者年龄,疾病,并发症指数和供体类型被确定为HSCT结果的强有力的预测指标 (一致性指数:0.677).
- 该计算器为每个潜在的捐赠者提供了估计的2年生存期,有助于决策过程.
结论:
- 一个原型工具已经开发出来,以帮助医生选择最佳的HSCT捐赠者.
- 该工具利用移植中心的现实数据来反映当地临床经验.
- 通过一项规模更大,正在进行的多中心研究,计划进一步改进该工具,以扩大其适用性.
更多相关视频
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
7.3K
10:11Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model
Published on: March 7, 2013
15.3K
相关概念视频
Bone Marrow Sampling and Transplants
284
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
284
Hematopoiesis
5.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.1K
